Long QT syndrome

Gene: TRDN

Amber List (moderate evidence)

TRDN (triadin)
EnsemblGeneIds (GRCh38): ENSG00000186439
EnsemblGeneIds (GRCh37): ENSG00000186439
OMIM: 603283, Gene2Phenotype
TRDN is in 3 panels

2 reviews

Ivone Leong (Genomics England Curator)

After NHS Genomic Medicine Service consideration, the rating of this gene has not been changed.
Created: 3 Mar 2022, 11:51 a.m. | Last Modified: 3 Mar 2022, 11:51 a.m.
Panel Version: 2.31
Comment on list classification: This gene has been downgraded from Green to Amber at the request of NHS England following discussion at a Rare Disease workshop.
Created: 19 Aug 2020, 9:27 a.m. | Last Modified: 19 Aug 2020, 9:27 a.m.
Panel Version: 2.17
Comment on list classification: New gene added by Zornitza Stark. This gene has been given a Green status based on the evidence, which supports a gene-disease association.
Created: 12 Jun 2020, 1:26 p.m. | Last Modified: 12 Jun 2020, 1:26 p.m.
Panel Version: 2.8

Zornitza Stark (Australian Genomics)

Green List (high evidence)

Gene-disease association rated as DEFINITIVE by ClinGen:
Evidence for involvement of TRDN in LQTS was based mainly on a single publication demonstrating 5 cases with homozygous or compound heterozygous frameshift variants. All cases presented during early childhood (up to the age of 3 years) with QT prolongation, negative T waves in precordial leads, and exercise-induced arrhythmias, although typical
torsades de pointes was demonstrated only in 1 case. Experimental evidence demonstrated that TRDN loss of function may lead to arrhythmogenesis but did not specifically show prolongation of repolarization, which is the hallmark of LQTS. Accordingly, there was a debate
within the panel as to whether the TRDN-related cardiac phenotype should be classified as CPVT or as a unique syndrome, referred in the literature as triadin knockout syndrome. Because QT prolongation was the most easily discernable abnormality, it was decided to consider these cases as having an atypical LQTS phenotype. Furthermore, it was agreed that there was strong evidence for TRDN’s disease association.
Sources: Expert list
Created: 1 Jun 2020, 10:45 a.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Long QT syndrome

Publications

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Amber
Phenotypes
  • Long QT syndrome
OMIM
603283
Clinvar variants
Variants in TRDN
Penetrance
None
Publications
Panels with this gene

History Filter Activity

3 Mar 2022, Gel status: 2

Removed Tag

Ivone Leong (Genomics England Curator)

Tag for-review was removed from gene: TRDN.

19 Aug 2020, Gel status: 2

Entity classified by Genomics England curator

Ivone Leong (Genomics England Curator)

Gene: trdn has been classified as Amber List (Moderate Evidence).

19 Aug 2020, Gel status: 3

Added Tag

Ivone Leong (Genomics England Curator)

Tag for-review tag was added to gene: TRDN.

12 Jun 2020, Gel status: 3

Entity classified by Genomics England curator

Ivone Leong (Genomics England Curator)

Gene: trdn has been classified as Green List (High Evidence).

1 Jun 2020, Gel status: 0

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Zornitza Stark (Australian Genomics)

gene: TRDN was added gene: TRDN was added to Long QT syndrome. Sources: Expert list Mode of inheritance for gene: TRDN was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: TRDN were set to 31983240; 25922419 Phenotypes for gene: TRDN were set to Long QT syndrome Review for gene: TRDN was set to GREEN